Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on July 10, 2026

Jul. 10, 2026

AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques

Indeterminate GlobeNewswire

Jul. 10, 2026

Cosmos Health Launches Subscription Model

Indeterminate GlobeNewswire

Jul. 10, 2026

SourcingGPT Revolutionizes Trade Show Sourcing at Eletrolar Show 2026

Indeterminate GlobeNewswire

Jul. 10, 2026

Vmake Labs Launches Brainrot Marketing Video Styles to Help Small Businesses Turn Products into Viral Social Videos

Indeterminate GlobeNewswire

Jul. 10, 2026

The Mobile Paradigm Shift: How Ecer.com Powers 24/7 "Always-On" Global Trade for Exporters

Indeterminate EIN Presswire

Jul. 10, 2026

AI-Driven Foreign Trade: How Ecer.com is Reshaping Global Growth for Exporters

Indeterminate EIN Presswire

Jul. 10, 2026

Seegnal Announces Listing on the Frankfurt Stock Exchange

Indeterminate GlobeNewswire

Jul. 10, 2026

Sprout Social Named as a Visionary in the 2026 Gartner® Magic Quadrant™ for Social Media Management and Listening

Indeterminate GlobeNewswire

Jul. 10, 2026

Palisade Bio to Participate in the Leerink Partners Therapeutics Forum

Indeterminate GlobeNewswire

Jul. 10, 2026

Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity

Indeterminate GlobeNewswire

Jul. 10, 2026

Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector

Indeterminate GlobeNewswire

Jul. 10, 2026

Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable

Indeterminate GlobeNewswire

Jul. 10, 2026

Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative

Indeterminate GlobeNewswire

Jul. 10, 2026

Micware Commences Full-Scale Spatial Intelligence Business for the Web4 Era

Indeterminate GlobeNewswire

Jul. 10, 2026

ミックウェア、Web4時代の空間インテリジェンス事業を本格始動

Indeterminate GlobeNewswire

Jul. 10, 2026

NordLocker rebuilds its encrypted cloud storage from the ground up

Indeterminate GlobeNewswire

Jul. 10, 2026

ThriveCart Launches Customer Advisory Council to Strengthen Transparency and Product Direction

Indeterminate GlobeNewswire

Jul. 10, 2026

SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma

Indeterminate GlobeNewswire

Jul. 10, 2026

Silo Pharma Announces up to $11.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Indeterminate GlobeNewswire

Jul. 10, 2026

VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Indeterminate GlobeNewswire